Eloxx Pharmaceuticals (ELOX) Receives a Buy from B.Riley Financial
March 31 2022 - 07:25PM
TipRanks
In a report released today, Mayank Mamtani from B.Riley Financial
maintained a Buy rating on Eloxx Pharmaceuticals (ELOX – Research
Report), with a price target of $3.00. The company's shares closed
last Thursday at $0.56, close to its 52-week low of $0.37.
According to TipRanks.com, Mamtani has 0 stars on 0-5 stars ranking
scale with an average return of -22.4% and a 27.8% success rate.
Mamtani covers the Healthcare sector, focusing on stocks such as
Arrowhead Pharmaceuticals, Madrigal Pharmaceuticals, and Spectrum
Pharmaceuticals. Currently, the analyst consensus on Eloxx
Pharmaceuticals is a Moderate Buy with an average price target of
$2.00.
https://www.tipranks.com/news/blurbs/eloxx-pharmaceuticals-elox-receives-a-buy-from-b-riley-financial?utm_source=advfn.com&utm_medium=referral
Eloxx Pharmaceuticals (NASDAQ:ELOX)
Historical Stock Chart
From Mar 2023 to Apr 2023
Eloxx Pharmaceuticals (NASDAQ:ELOX)
Historical Stock Chart
From Apr 2022 to Apr 2023
